Brief: Gentian Diagnostics Q2 EBITDA At NOK 6.8 Mln
Aug 29 (Reuters) - GENTIAN DIAGNOSTICS ASA GENT.OL :
* SALES OF NOK 38.3 MILLION IN 2Q24, UP 12% VERSUS 2Q23 (13%
ORGANIC GROWTH). REVENUE
* EBITDA OF NOK 6.8 MILLION IN 2Q24 VERSUS NOK 3.6 MILLION
IN
2Q23.
* REVENUE OF NOK 76.8 MILLION IN 1H24 UP 17% VERSUS 1H23
(16%
ORGANIC GROWTH)
* EBITDA OF NOK 11.6 MILLION IN 1H24 VERSUS NOK 3.1 MILLION
IN
1H23
Source text for Eikon: ID:nObiY1vkwa
Further company coverage: GENT.OL
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company